Regular Article
Pyrroloquinoline Quinone Acts with Flavin Reductase to Reduce Ferryl Myoglobin in Vitro and Protects Isolated Heart from Reoxygenation Injury

https://doi.org/10.1006/bbrc.1993.1642Get rights and content

Abstract

Pyrroloquinoline quinone has been isolated from bacteria and recently has been detected in mammalian tissues and fluids. We report in vitro studies which show that pyrroloquinoline quinone serves as a high-affinity substrate for an erythrocyte "flavin reductase" and that the pyrroloquinoline quinol generated by this catalysis reacts rapidly with ferryl myoglobin radical. Western blot analysis of rat and rabbit heart homogenates detects a cross-reactive protein which has a molecular weight identical to the erythrocyte reductase from the same species. Low concentrations of pyrroloquinoline quinone protect isolated rabbit heart from reoxygenation injury, serving as an effective tissue-protective agent in this model for cellular oxidative damage. We propose that this tissue protection is due to a pyrroloquinoline quinol-mediated reduction of reactive oxygen species.

References (0)

Cited by (46)

  • In silico and crystallographic studies identify key structural features of biliverdin IX reductase inhibitors having nanomolar potency

    2018, Journal of Biological Chemistry
    Citation Excerpt :

    In humans, biliverdin reductase IXα (BLVRA) (10–12) effectively reduces BV IXα with less efficient utilization of BV IXβ, IXγ, or IXδ (13). In contrast, biliverdin IXβ reductase (BLVRB) is promiscuous (14, 15), catalyzing the NAD(P)H-dependent reduction of non-IXα biliverdin isomers (IXβ, IXγ, and IXδ) (16), and several flavins, including flavin mononucleotide (FMN) (17), pyrroloquinoline quinone (18), dichlorophenolindophenol (DCPIP), and ferric ion (Fig. 1a) (18). A single dinucleotide-binding domain accommodates both NADPH (or NADH) and substrate(s) within the verdin/flavin (V/F) binding pocket, with no evidence to date for structural or preferred partitioning for either substrate.

  • Ultrasensitive determination of pyrroloquinoline quinone in human plasma by HPLC with chemiluminescence detection using the redox cycle of quinone

    2017, Journal of Pharmaceutical and Biomedical Analysis
    Citation Excerpt :

    Pyrroloquinoline quinone (PQQ, 4,5-dihydro-4,5-dioxo-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid) is a cofactor for methanol dehydrogenase [1] and is categorized as a member of the vitamin B family [2]. PQQ plays important roles in mammals, including protection against liver [3], heart [4], and brain injuries [5], enhancement of the synthesis of DNA in human fibroblasts [6], and promotion of the production of the nerve growth factor [7]. In addition, it has a defensive effect against embryonic cataract induced by hydrocortisone [8] and acts as a radical scavenger [9,10].

  • Reperfusion injury and reactive oxygen species: The evolution of a concept

    2015, Redox Biology
    Citation Excerpt :

    The oxidative stress elicited in tissues/cells following I/R (or H/R) has been linked to a variety of different sources of ROS. Non-enzymatic sources of ROS, such as hemoglobin and myoglobin (both of which can be released into extracellular fluid after trauma), have received some attention as potential mediators of I/R-induced oxidative stress [115,116]. However, most studies have attributed the accelerated ROS production in post-ischemic tissues to one or more enzymes that are capable of reducing molecular oxygen to form superoxide and/or hydrogen peroxide, with the subsequent release of ROS into the intracellular and/or extracellular compartments.

  • Biosynthesis and Biological Functions of Bilins

    2012, The Porphyrin Handbook: Chlorophylls and Bilins: Biosynthesis, Synthesis and Degradation
View all citing articles on Scopus
View full text